<DOC>
	<DOC>NCT00660855</DOC>
	<brief_summary>The objectives of this study were to assess the analgesic efficacy and safety of parecoxib/valdecoxib on post-laparoscopic surgery analgesia.</brief_summary>
	<brief_title>A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain</brief_title>
	<detailed_description>This study A3471107 was terminated on February 4th, 2005 due to enrollment difficulties, problems related to need for rescue medication, and perceptions about cardiovascular risk potentially associated with all NSAIDs.</detailed_description>
	<mesh_term>Valdecoxib</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Patients who had undergone laparoscopic surgery Patients in need of postsurgical analgesia Patients with an unexpected surgical complication which, in the Investigator's opinion, placed the patient at significantly higher risk for postsurgical complication(s), or for nonroutine postoperative care requirements Patients who took any nonsteroidal antiinflammatory drug or any analgesic within 48 hours prior to surgery</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>laparoscopy</keyword>
</DOC>